Delhi High Court

The regulator said the company had not provided financial data sought in a case over its App Store payment rules.

Delhi High Court pauses Olymviq rollout after Novo Nordisk argues the name is too close to Ozempic just days after semaglutide patent protection expired in India.

Case tests legality of India’s shift to competition penalties based on worldwide turnover amid competition watchdog's claim that Apple’s challenge is aimed at delaying its App Store investigation.